Q4 2019 Photocure ASA Earnings Call Transcript
All right? All right. Good morning. Good morning, everyone. Welcome to Photocure's end of the year 2019 and Q4 presentation. I'm Dan Schneider, President and CEO. With me today is Erik Dahl, CFO. And I press the button. Usual disclaimers are in place for today's presentation.
So quick highlights on 2019. We continued positive growth rates in all regions of the world, Nordics, U.S. and our partner countries. As I mentioned last year, we put pressure on our partners in Europe, Ipsen, and they have responded in some of their countries, particularly Germany. We've had extremely strong revenue growth in the U.S. with fiscal year increase of 43%. It now represents about 50% of our total sales. If you remember, beginning 2018, it represented around 30%. So as this region of the world's business continues to grow, it have a greater impact on the total business of Photocure.
Our installed base of rigid and flex blue light cystoscopies is now 223. That was an increase of 66 scopes, 26 of them flexible scopes used in the surveillance market,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |